The NeurologyLive® neuromuscular disease clinical focus page offers updates and information related to the clinical care and management of individuals with neuromuscular diseases such as amyotrophic lateral sclerosis, Duchenne muscular dystrophy, cerebral palsy, and spinal muscular atrophy, as well as rare diseases. This page consists of news, podcasts, and videos about the latest FDA actions, clinical guideline updates, interviews with physicians, study and clinical trial findings, and more.

Latest News

Patrick Horn MD, PhD  (Credit: Fulcrum)
Losmapimod Shows Potential for Facioscapulohumeral Muscular Dystrophy Despite Not Meeting Primary End Point

May 22nd 2024

The phase 3 REACH trial investigating Fulcrum Therapeutics’ losmapimod in patients with facioscapulohumeral muscular dystrophy remains on track with topline data anticipated in the fourth quarter of 2024.

Stephanie Richardson, MS, CCC-SLP  (Credit: Brooks Rehabilitation)
Swallow This: Treating Dysphagia with Speech Pathology

May 22nd 2024

Carole Ben-Maimon, MD  (Credit: Larimar)
FDA Removes Partial Clinical Hold on Nomlabofusp Program for Friedreich Ataxia

May 21st 2024

ION582 Improves Cognition, Motor Function, and Communication in Phase 1/2 Trial of Angelman Syndrome
ION582 Improves Cognition, Motor Function, and Communication in Phase 1/2 Trial of Angelman Syndrome

May 21st 2024

Neuro News Roundup: Chronic Demyelinating Polyneuropathy Awareness Month – Expert Insight and Latest Literature
Neuro News Roundup: Chronic Demyelinating Polyneuropathy Awareness Month – Expert Insight and Latest Literature

May 20th 2024

Latest CME Events & Activities

Improving Care for Patients with Motor Complications of Parkinson Disease: Role of Technology and Data

View More

Clinical Consultations™: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis

View More

Evolving Perspectives in Alzheimer's Disease: Reaching an Earlier Diagnosis, Understanding Neuroinflammation, and Exploring Therapeutic Advances

September 15, 2024

Register Now!

Mastering MS: Translating Evidence into Optimal Management Plans

View More

Advances In Treating Migraine in Your OB/GYN Practice: Navigating Treatment Paradigms to Improve Patient Care

View More

Recognizing Rett Syndrome Early to Improve Long-term Management Outcomes

View More

5th Annual International Congress on the Future of Neurology®

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Advances In™ Generalized Myasthenia Gravis: Improving Patient Outcomes Through Early Diagnosis and Management

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

Burst CME: Optimizing Therapy in Parkinson’s Disease

View More

Community Practice Connections™: Transforming Multiple Sclerosis Care – Clinical Updates on the Effects of BTK Inhibitors

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

Burst Expert Illustrations & Commentary™: Visualizing the Role of the Complement Pathway in Neurological Disorders

View More

Burst Expert Illustrations & Commentary™: Visualizing the Implications of Anti-Complement Therapies on Generalized Myasthenia Gravis

View More

Burst Expert Illustrations & Commentary™ : Visualizing the Role of the Complement Proteins in Neurologic Disorders

View More

Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients

View More

Individualizing Treatment for Patients with Generalized Myasthenia Gravis

View More

Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans

View More

Clinical ShowCase™ in ALS: Addressing Diagnostic Delays, Evolving Therapies, and Multidisciplinary Care

View More

More News

© 2024 MJH Life Sciences

All rights reserved.